Results from a new study co-led by researchers at Dartmouth’s Geisel School of Medicine and the Department of Surgery at Kuma Hospital in Kobe, Japan, show that active surveillance can be successfully implemented as a viable treatment option for patients with low-risk thyroid cancer.
Post Tagged with: "The Dartmouth Institute"
Carolyn Murray, MD, MPH, an assistant professor at Dartmouth’s Geisel School of Medicine, has received a national award from the American College of Preventive Medicine for outstanding contributions to preventive medicine and public health.
New findings from a Dartmouth-led study, published in the August issue of Health Affairs, show that larger, more integrated healthcare systems do not generally deliver better quality care, and urge policy makers to ensure that mergers or acquisitions due to pandemic-associated financial stress adhere to current antitrust law.
A $1-million gift from Susan and Richard Levy D ’60 will fuel the rapid-cycle development and testing of new ways of caring for individuals with serious illnesses. The couple’s gift to the Geisel School of Medicine at Dartmouth launches the Susan & Richard Levy Health Care Delivery Incubator.
A new Dartmouth-led paper published in the New England Journal of Medicine highlights that more emphasis should be placed on addressing the inaccuracy of COVID-19 diagnostic tests.
Carrie Colla, PhD, an associate professor of The Dartmouth Institute for Health Policy and Clinical Practice at Dartmouth’s Geisel School of Medicine, has been named a 2020 Emerging Leader in Health and Medicine Scholar by the National Academy of Medicine (NAM).
New findings from a Dartmouth-led study, published in the February issue of Health Affairs, show that despite effort and attention on the part of some healthcare providers to better address their patients’ social needs, little progress is being made to integrate social services with medical care.
A new Dartmouth study finds that pharmaceutical companies’ promotional access to outpatient practices that deliver primary care in the U.S. is substantial, especially in smaller practices, those outside of healthcare systems, and those without academic affiliation, possibly impacting prescribing quality and cost.
Findings from a new study led by researchers at Dartmouth’s Geisel School of Medicine show that the way in which pharmaceutical companies are permitted to share information about their drugs can influence physician prescribing practices.
A new study from The Dartmouth Institute for Health Policy and Clinical Practice, published this week in JAMA Network Open, finds that most U.S. physician practices and hospitals report screening patients for at least one social need, a trend that is expected to increase in the future, and that practices that care for disadvantaged patients report higher screening rates.